Navigation Links
Farmers Across the U.S. Realize Double-Digit Yield Advantage From DEKALB(R) Corn Seeds With Triple-Stacked Traits

DEKALB Genetics Show More Than 12 Bushel Per Acre Yield Advantage in Key

Maturity Zone

ST. LOUIS, Dec. 14 /PRNewswire-FirstCall/ -- Harvest data from across the United States showed that farmers who used DEKALB(R) corn seed stacked with YieldGard VT Triple(TM) from Monsanto Company (NYSE: MON) saw double-digit yield advantage over competing seed corn brands and technologies in 2007.

Data from nearly 1,700 on-farm field trials showed an average of more than 14.6 bushel per acre advantage for DEKALB YieldGard VT Triple compared to Pioneer varieties which included Herculex Xtra. In Iowa, Illinois, and Nebraska, the DEKALB YieldGard VT Triple advantage grew to 15.0, 16.9, and 17.2 bushels per acre respectively.

"These yield figures show the powerful and tangible results that come about when elite germplasm and biotechnology combine," said Jim Zimmer, U.S. Branded Business Lead for Monsanto Company. "For more than 70 years, DEKALB products have stood for strong roots and yields and our results in 2007 really underscore that statement."

DEKALB Genetics Outshine Competitors

Genetics from DEKALB brand seeds yielded an average of more than 8 bushels per acre over competing genetics according to 2007 harvest results. This margin widened to more than 12 bushels per acre in the 110-day maturity zone, the selection most often used in top corn producing states in the Corn Belt. Other zones also saw significant yield advantage from DEKALB genetics, including:

-- 7.8 bushels per acre, 95 RM Zone

-- 10.4 bushels per acre, 100 RM Zone

-- 5.1 bushels per acre, 105 RM Zone

-- 5.5 bushels per acre, 115 RM Zone.

"Our researchers tap into the world's largest corn germplasm pool to find the best genetics from anywhere in the world that brings greater yields to farmers here in the United States," said Jason Hoag, DEKALB Marketing Manager. "You can see the benefits from that pool in these results."

The DEKALB brand of corn seed has seen six consecutive years of market share gains in the U.S. corn seed market, growing to 23 percent market share or more than doubling its presence in the market in the last five years.

To continue to keep pace with growing demands, Monsanto has recently announced manufacturing expansions in Nebraska and Iowa that will more than double corn seed production in both states. Combined, Monsanto is investing more than $380 million in both states to expand existing corn seed operations and build two new DEKALB corn seed conditioning facilities.

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see

Individual results may vary, and performance may vary from location to location and from year to year. This result may not be an indicator of results you may obtain as local growing, soil and weather conditions may vary. Growers should evaluate data from multiple locations and years whenever possible. Always follow grain marketing and insect resistance management requirements, and follow pesticide label directions. YieldGard products are not yet registered in all states. Check with your Monsanto representative for the registration status in your state. DEKALB(R) is a registered trademark of DeKalb Genetics Corporation. YieldGard(R), YieldGard VT(TM) and YieldGard VT Triple(TM) are trademarks of Monsanto Technology LLC. All other trademarks are the property of their respective owners. (C)2007 Monsanto Company.

SOURCE Monsanto Company
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
2. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
3. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
4. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
5. Collaboration yields the right glasses for observing mystery behavior in electrons
6. BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
7. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
8. Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
Breaking Biology News(10 mins):